Topic

Assembly Biosciences

1 recent story · updated continuously

Benzinga

Assembly Biosciences Expands ABI-6250 Development to Target Cholestatic Liver Diseases

healthJust now
Assembly Biosciences Expands ABI-6250 Development to Target Cholestatic Liver Diseases